Supporting evidence from the PROGgeneV2 database showed that high <i>PIK3CA</i> mRNA levels predicted inferior survival in external cohorts.<h4>Conclusions</h4>p110α protein expression is an independent biomarker for adverse outcomes in stage I-III invasive breast cancer. This evidence concerns the gene PIK3CA and invasive breast carcinoma.